Welcome to SoliPharma

SoliPharma is a specialty pharmaceutical company with pharmaceutical innovation center based in Hangzhou, China and business development/product registration office in U.S.
SoliPharma’s mission is to “bringing challenging molecules to global markets” faster and better through SoliTech® Solutions. We focus on providing comprehensive solutions to our clients worldwide from early API development (solid form screening/crystallization process), to drug product development (formulation/analytical chemistry), until obtaining the final approval of market authorization (FDA GMP/regulatory affair).

About Us

With our track record in China/U.S./Canada/European product innovation and business relationship, SoliPharma strives for delivering both innovative products (505(b)2 with modified release/new combinations) and difficult generic products (NTI, highly variable, IP hurdles etc). Leveraging global partnership with API suppliers, contract manufacturing and product distribution, SoliPharma is devoted to bringing medical products faster to meet patients’ urgent and unmet medical needs.

SoliTech® Solutions

  • Organ Transplant
  • Blood Cell Disorders
  • Urological Disease

Bring Challenging Molecules to the Global Markets

SoliPharma is a specialty pharmaceutical company. We provide technical solutions to both innovative and difficult generic products for global markets.

Excellence in Business since 2010

SoliPharma is a specialty pharmaceutical company with pharmaceutical innovation center based in Hangzhou, China and business development/product registration office in U.S.

500+ Compounds

领业的使命是将有挑战性的药物分子带向市场,我们的SoliTech®“一致性评价”解决方案为全球客户提供从原料药的晶型研究。

10000+ Testings per year

专注于(盐型/晶型/共晶筛选、结晶工艺开发)、产品开发(处方制剂、分析方法)、直到获得产品批文(FDA GMP、注册法规)。

500+ Customers

领业团队在中国/北美/欧洲有十多年的产品创新及商务开发经验,我们致力于为全球各个国家和市场开发具有挑战性和创新性的特色药品。

5 Strategic Partners

专业规范的技术和及时准确的沟通为客户带来可靠的价值体验,也为领业同5家国内外企业建立的长期战略合作伙伴关系打下坚实基础。

image-box
领业零缺陷通过美国cGMP检查

2018年8月27日至29日,美国FDA检查官在对领业医药质量管理体系现场核查总结会上,直接宣布并祝贺领业医药以483零缺陷通过...

image-box
领业董事长出席胃癌国际论坛

2017年11月17日到19日,第十七届全军普通外科专业委员会学术会议暨第三届长征胃癌国际论坛于上海隆重召开。

image-box
领业成功实现片剂开发

技术服务类型:临床前处方及制剂研究,制剂工艺开发及产业化,仿制药固体制剂质量一致性评价

image-box
领业医药首轮融资签约仪式

2015年9月10日上午10点, 在杭州高科技企业孵化器多功能厅隆重举行“领业医药首轮融资签约仪式”。